Pancreatic Cancer Research

ResearcherUniversidade de Santiago de CompostelaNo recent work listed

Julio Iglesias‐García

Matched on ORCID iD 0000-0002-3517-329X; OpenAlex author ID A5020246740. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 9

  1. Emergent endoscopic ultrasound-guided cholecystoduodenostomy does not prevent R0 resection in a pancreaticoduodenectomy for pancreatic cancer. Co-author DOI 10.1007/s12328-021-01540-1↗
  2. Endoscopic Pancreatic Drainage Improves Exocrine Pancreatic Function in Patients With Unresectable Pancreatic Cancer: A Double-Blind, Prospective, Randomized, … Last author DOI 10.1097/mpa.0000000000001817↗
  3. Early pancreatic cancer - The role of endoscopic ultrasound with or without tissue acquisition in diagnosis and staging. First author DOI 10.1016/j.dld.2018.09.027↗
  4. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. Last author DOI 10.1186/s12885-018-4439-x↗
  5. Biliary drainage in pancreatic cancer: The endoscopic retrograde cholangiopancreatography perspective. Last author DOI 10.4103/eus.eus_79_17↗
  6. Interobserver agreement and accuracy of preoperative endoscopic ultrasound-guided biopsy for histological grading of pancreatic cancer. Co-author DOI 10.1055/s-0034-1390912↗
  7. Early detection of pancreatic cancer in patients with intraductal papillary mucinous neoplasms: the pivotal role of endoscopic ultrasound Co-author DOI 10.1055/s-0033-1359176↗
  8. The role of EUS in relation to other imaging modalities in the differential diagnosis between mass forming chronic pancreatitis, autoimmune pancreatitis and du… Co-author DOI 10.4321/s1130-01082012000600006↗
  9. Early diagnosis of pancreatic cancer, time to screen high-risk individuals? Co-author PMID 21587149↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. J. Enrique Domínguez‐Muñoz · 6 shared papers, 2012–2022 · strength 0.64
  2. José Lariño‐Noia · 4 shared papers, 2011–2022 · strength 0.42
  3. Daniel de la Iglesia · 2 shared papers, 2021–2022 · strength 0.30
  4. Pedro Moutinho-Ribeiro · 1 shared paper, 2019 · strength 0.14
  5. Guilherme Macedo · 1 shared paper, 2019 · strength 0.14
  6. Alberto Larghi · 1 shared paper, 2015 · strength 0.05
  7. Guido Costamagna · 1 shared paper, 2015 · strength 0.05
  8. Guido Rindi · 1 shared paper, 2015 · strength 0.05
  9. Marc F. Giovannini · 1 shared paper, 2015 · strength 0.05
  10. Domínguez-Muñoz Je · 1 shared paper, 2011 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.